LGC to develop new Berlin site to expand Nucleic Acid Therapeutics capacity

News (ZH) - Site will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics

LGC’s commitment to carbon net zero

News (ZH) - LGC is committing to being carbon net zero by 2050

LGC supports British Pharmacopoeia 2022

博客 - LGC’s MHRA Laboratories Team supports the annual BP publication by providing physico-chemical analysis of substances

LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News (ZH) - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

LGC instruments support important milestones

博客 - LGC’s validated technology provides gold-standard sensitivity and specificity based on clinical data, as well as material cost and time savings.

World Standards Day 2021

博客 - On 14th October, we celebrate World Standards Day. Documentary standards provide an agreed “best way of doing things”, based on expert knowledge and best practice from across the world.

Measurement science improves standardisation of SARS-CoV-2 quantification

News (ZH) - NML team analysis vital to understanding potential discrepancies in measured viral burden used to manage CoVid-19 pandemic

LGC's "incredibly critical" ultra-high-throughput CoVid workflow spotlighted in GenomeWeb

博客 - Mark Dearden recently spoke with GenomeWeb to discuss CoVid workflow and much more besides

LGC launches SARS-CoV-2 Delta Variant quality solution

News (ZH) - Safe, non-infectious, and replication deficient quality solution for Delta variant detection and analysis

Euan O’Sullivan appointed CEO of LGC

News (ZH) - Euan succeeds Tim Robinson, who will become Chairman of LGC